cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25934/00000826.1
title: IPD datapackage for study 'A Six Week Randomized, Double-blind, Multi-center, Placebo-controlled, Exploratory, Adaptive Design Study to Explore the Antidepressant Properties of the p38 MAP Kinase Inhibitor GW856553 Compared to Placebo in Adult Subjects With Major Depressive Disorder' and research request: 'Interleukin-6 distribution in plasma/serum'

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5281/zenodo.3553059
title: DAMP-VSEP: Smule Digital Archive of Mobile Performances - Vocal Separation

description: This dataset contains audio content for performing vocal separation research. It contains performances with (1) backing tracks, (2) one or more isolated vocals files, and (3) a mixture of the two. This is a real-world dataset from performances on the Smule app, which includes non-linear effects processes on the mixture of vocals and backing track. The dataset contains data from 155 countries, 36 languages, 6456 artists, and 11494 compositions. Users of this dataset must read and accept Smule's Research Data License Agreement (LICENSE.txt).
DOI: 10.5519/qd.29j6i0my
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (1 records)
DOI: 10.7910/dvn/drvbzy/70ibul
title: Rosenberg_et_al_analysis_code.R

description: R file that replicates the map, sensitivity tests, and Bayesian analysis.
DOI: 10.7910/dvn/drvbzy/gj2sr2
title: Rosenberg_et_al_dataprocessing_code.do

description: Stata do file that generates the variables necessary to replicate our analysis.
DOI: 10.7910/dvn/drvbzy/i3ty0f
title: Rosenberg_et_al_analysis_code.do

description: Stata do file that replicates the main results (except those completed in the R file Rosenberg_et_al_analysis_code.R).
DOI: 10.7910/dvn/drvbzy/woj5as
title: ReadMe.txt

description: ReadMe file -- please start here!
DOI: 10.25934/00005065
title: Fracture Incidence Reduction And Safety Of TSE-424 (Bazedoxifene Acetate) Compared To Placebo And Raloxifene In Osteoporotic Postmenopausal Women

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00005066
title: A Double-Blind, Randomized, Placebo And Active- Controlled Efficacy And Safety Study Of The Effects Of Bazedoxifene/Conjugated Estrogens Combinations On Endometrial Hyperplasia And Prevention Of Osteoporosis In Postmenopausal Women

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5281/zenodo.3554966
title: glottolog/glottolog-cldf: Glottolog database 4.1 as CLDF

description: Hammarström, Harald & Forkel, Robert & Haspelmath, Martin. 2019. Glottolog 4.1. Jena: Max Planck Institute for the Science of Human History. (Available online at https://glottolog.org)
DOI: 10.6073/pasta/7409df4a83ddd3327cf64cde4d9a7927
title: North Temperate Lakes LTER: Physical Limnology of Primary Study Lakes 1981 - current

description: Parameters characterizing the physical limnology of the eleven primary lakes (Allequash, Big Muskellunge, Crystal, Sparkling, Trout, bog lakes 27-02 [Crystal Bog] and 12-15 [Trout Bog], Mendota, Monona, Wingra and Fish) are measured at one station in the deepest part of each lake at 0.25-m to 1-m depth intervals depending on the lake. Measured parameters in the data set include water temperature, vertical penetration of photosynthetically active radiation (PAR; not measured on lakes Mendota, Monona, Wingra, and Fish), dissolved oxygen, as well as the derived parameter percent oxygen saturation. Sampling Frequency: fortnightly during ice-free season - every 6 weeks during ice-covered season for the northern lakes. The southern lakes are similar except that sampling occurs monthly during the fall and typically only once during the winter (depending on ice conditions). Number of sites: 11
DOI: 10.5281/zenodo.3554960
title: Preparation of ultrafine fibrous uranium dioxide by electrospinning_experimental dataset

description: This dataset contains the raw underlying data for the paper "Preparation of ultrafine fibrous uranium dioxide by electrospinning" available in open acess under DOI 10.5281/zenodo.3553488.
description: This research has been financially supported by the MEYS CR under the project CEITEC 2020 (LQ1601) and the Horizon 2020 Research and Innovation Program under the grant agreement no. 810626 (SINNCE). CIISB research infrastructure project LM2015043 funded by the MEYS CR is gratefully acknowledged for the financial support of the measurements at the CEITEC MU CF X-ray Diffraction and Bio-SAXS and the CF Cryo-electron Microscopy and Tomography.
DOI: 10.5281/zenodo.3554961
title: Preparation of ultrafine fibrous uranium dioxide by electrospinning_experimental dataset

description: This dataset contains the raw underlying data for the paper "Preparation of ultrafine fibrous uranium dioxide by electrospinning" available in open acess under DOI 10.5281/zenodo.3553488.
description: This research has been financially supported by the MEYS CR under the project CEITEC 2020 (LQ1601) and the Horizon 2020 Research and Innovation Program under the grant agreement no. 810626 (SINNCE). CIISB research infrastructure project LM2015043 funded by the MEYS CR is gratefully acknowledged for the financial support of the measurements at the CEITEC MU CF X-ray Diffraction and Bio-SAXS and the CF Cryo-electron Microscopy and Tomography.
DOI: 10.3886/e115801v1
title: Understanding Racial/Ethnic Diversity Gaps Among Early Career Teachers

description: This memo documents the data files and analysis files used to generate the estimates found in “Understanding Racial/Ethnic Diversity Gaps Among Early Career Teachers.” <br><br>The abstract for the paper is found below:<br>The growing evidence on the importance of teacher representation points to the need to better understand the factors shaping the lack of racial/ethnic diversity in the teacher workforce. In this study, we examine the extent to which college major choice explains racial/ethnic gaps in teaching. Drawing on data from the Baccalaureate and Beyond Longitudinal Study, we find that White college graduates are close to twice as likely to major in education compared to Black, Latinx, and other graduates of color. Even among college graduates, respondents who identify as White are 5 percentage points more likely to enter teaching than respondents who identify as Black and 2 percentage points more likely to enter teaching than graduates who identify as Latinx. Regression and decomposition analyses demonstrate that the observed racial/ethnic gaps in entry to teaching can largely be explained by whether a graduate studied education in college.<br>
DOI: 10.3886/e115801
title: Understanding Racial/Ethnic Diversity Gaps Among Early Career Teachers

description: This memo documents the data files and analysis files used to generate the estimates found in “Understanding Racial/Ethnic Diversity Gaps Among Early Career Teachers.” <br><br>The abstract for the paper is found below:<br>The growing evidence on the importance of teacher representation points to the need to better understand the factors shaping the lack of racial/ethnic diversity in the teacher workforce. In this study, we examine the extent to which college major choice explains racial/ethnic gaps in teaching. Drawing on data from the Baccalaureate and Beyond Longitudinal Study, we find that White college graduates are close to twice as likely to major in education compared to Black, Latinx, and other graduates of color. Even among college graduates, respondents who identify as White are 5 percentage points more likely to enter teaching than respondents who identify as Black and 2 percentage points more likely to enter teaching than graduates who identify as Latinx. Regression and decomposition analyses demonstrate that the observed racial/ethnic gaps in entry to teaching can largely be explained by whether a graduate studied education in college.<br>
DOI: 10.5281/zenodo.3555321
title: Large-scale purification of Q23 HTT-HAP40 from Sf9 expression system with contaminating nucleic acid material 2019/09/16

description: <strong>Project: </strong>Biophysical investigation of purified HTT protein samples <strong>Experiment: </strong>Large-scale purification of Q23 HTT-HAP40 from Sf9 expression system with contaminating nucleic acid material <strong>Date completed:­ </strong>2019/09/16 <strong>Rationale:</strong> To purify HTT-HAP40 + Sf9 derived nucleic acid material for cryoEM analysis
description: Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
DOI: 10.5281/zenodo.3555322
title: Large-scale purification of Q23 HTT-HAP40 from Sf9 expression system with contaminating nucleic acid material 2019/09/16

description: <strong>Project: </strong>Biophysical investigation of purified HTT protein samples <strong>Experiment: </strong>Large-scale purification of Q23 HTT-HAP40 from Sf9 expression system with contaminating nucleic acid material <strong>Date completed:­ </strong>2019/09/16 <strong>Rationale:</strong> To purify HTT-HAP40 + Sf9 derived nucleic acid material for cryoEM analysis
description: Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
DOI: 10.17632/h8n4x5mwxb.1
title: Data for: Petrogenesis of the East Fork Member Rhyolites of the Jemez Volcanic Field, Valles caldera, New Mexico, USA
DOI: 10.5281/zenodo.3555338
title: Large-scale purification of Q23 and Q54 HTT-HAP40 from Sf9 expression system in PBS 2019/09/16

description: <strong>Project: </strong>Biophysical investigation of purified HTT protein samples <strong>Experiment: </strong>Large-scale purification of Q23 and Q54 HTT-HAP40 from Sf9 expression system in PBS. <strong>Date completed:­ </strong>2019/09/16 <strong>Rationale: </strong>To purify HTT-HAP40 Q23 and Q54 in PBS to see if this reduces nucleic acid contamination.
description: Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
DOI: 10.5281/zenodo.3555339
title: Large-scale purification of Q23 and Q54 HTT-HAP40 from Sf9 expression system in PBS 2019/09/16

description: <strong>Project: </strong>Biophysical investigation of purified HTT protein samples <strong>Experiment: </strong>Large-scale purification of Q23 and Q54 HTT-HAP40 from Sf9 expression system in PBS. <strong>Date completed:­ </strong>2019/09/16 <strong>Rationale: </strong>To purify HTT-HAP40 Q23 and Q54 in PBS to see if this reduces nucleic acid contamination.
description: Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
DOI: 10.5063/f1t43rfb
title: Reproductive coordination breeds success: the importance of the partnership in avian sperm biology

description: Previous experience with a partner can improve reproductive coordination between a pair and increase offspring production. We paired inexperienced zebra finches and investigated how a pairs’ experience and their reproductive success together (i.e. whether they were successful or unsuccessful at rearing chicks) related to the number of sperm reaching the ovum, sperm motile performance, and hatching success. In contrast to unsuccessful pairs, successful pairs increased their relative hatching rates over sequential breeding attempts, with pairs hatching 100% of eggs after successfully fledging their previous clutch. Across the study, hatching failure was primarily due to early embryo death. Further, the number of sperm reaching the perivitelline layer (PVL) significantly decreased after fledging chicks in successful pairs, and overall less sperm was found on the PVL in successful pairs compared to unsuccessful pairs. Across breeding attempts, males in successful pairs also exhibited a significant decline in sperm swimming speed, whereas it increased over breeding attempts in unsuccessful pairs. Our results support the idea of an optimal level of supernumerary sperm on the avian egg. However, our data suggest that there are likely to be interactions between the quality of a partnership and male sperm traits that may contribute to fitness in socially monogamous birds and that have been largely neglected to date.
DOI: 10.5281/zenodo.3555231
title: Inputdata for NorESM2.1.0 hybrid run with restart in 1701-01-01 compset N1850 (fully coupled) at f19_tn14

description: Compset longname is 1850_CAM60%NORESM_CLM50%BGC-CROP_CICE%NORESM-MIP6_MICOM%ECO_MOSART_SGLC_SWAV_BGC%BDRDDMS Copy the content of the 1701-01-01-00000 folder in the run directory, then change RUN_TYPE and RUN_REFCASE
DOI: 10.5281/zenodo.3555230
title: Inputdata for NorESM2.1.0 hybrid run with restart in 1701-01-01 compset N1850 (fully coupled) at f19_tn14

description: Compset longname is 1850_CAM60%NORESM_CLM50%BGC-CROP_CICE%NORESM-MIP6_MICOM%ECO_MOSART_SGLC_SWAV_BGC%BDRDDMS Copy the content of the 1701-01-01-00000 folder in the run directory, then change RUN_TYPE and RUN_REFCASE
DOI: 10.7910/dvn/vrauah/3a01zo
title: KE observer checklist_fp.doc

description: :unav
DOI: 10.7910/dvn/vrauah/eukixr
title: CA client exit questionnaire_combined fp-anc-pnc.doc

description: :unav
DOI: 10.7910/dvn/vrauah/hslj8a
title: voucher_anc_pooled.tab

description: :unav
DOI: 10.7910/dvn/vrauah/ikukcg
title: KE client exit questionnaire_combined fp-anc-pnc(translated).doc

description: :unav
DOI: 10.7910/dvn/vrauah/l0byew
title: KE observer checklist_pnc.doc

description: :unav
DOI: 10.7910/dvn/vrauah/ngjrel
title: Codebook_ANC FP PNC.tab

description: :unav
DOI: 10.7910/dvn/vrauah/pzqiuv
title: voucher_fp_pooled.tab

description: :unav
DOI: 10.7910/dvn/vrauah/utkd7p
title: KE observer checklist_anc.doc

description: :unav
DOI: 10.7910/dvn/vrauah/vi0yux
title: BD Client Provider Interactions- 10 oct English.doc

description: :unav
DOI: 10.7910/dvn/vrauah/ytepva
title: CA observer checklist_anc.docx

description: :unav
DOI: 10.7910/dvn/vrauah/2sszpd
title: BD Exit Client- 10 oct English.doc

description: :unav
DOI: 10.7910/dvn/vrauah/7k5dki
title: CA observer checklist_pnc.doc

description: :unav
DOI: 10.7910/dvn/vrauah/7ybclf
title: MNCH Validation_Readme-1.pdf

description: :unav
DOI: 10.7910/dvn/vrauah/ar1ytd
title: CA observer checklist_fp.doc

description: :unav
DOI: 10.7910/dvn/vrauah/kdroop
title: voucher_pnc_pooled.tab

description: :unav
DOI: 10.5281/zenodo.3541646
title: OpenAIRE ScholeXplorer Service: Scholix JSON Dump

description: This dataset contains the GZ-compressed dump of the Scholix links (schema Version 3) exposed by the OpenAIRE ScholeXplorer service. The dataset doubled since its last version and consists of 240+Mi bi-directional links (i.e. 480+Mi directed links) between literature-dataset and dataset-dataset involving 17+ Mi literature objects and 50+ Mi datasets. Links were collected from publishers (CrossRef, EventData), data centers (DataCite), institutional/thematic repositories (OpenAIRE), and life-science databases (EMBL-EBI). The links are organized in ~1000 compressed files, each of at most 50MB, for a total of ~38GB.
DOI: 10.18170/dvn/egfex8
title: Electrical resistivity simulation of hydrate-bearing sediment on pore network modeling

description: Data in figures
DOI: 10.5281/zenodo.3555358
title: Large-scale purification of Q23 HTT from Sf9 2019/09/30

description: <strong>Project: </strong>Biophysical investigation of purified HTT protein samples <strong>Experiment: </strong>Large-scale purification of Q23 HTT from Sf9 <strong>Date completed:­ </strong>2019/09/30 <strong>Rationale: </strong>HTT samples are to be purified from different systems for subsequent biophysical and structural studies.
description: Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
DOI: 10.5281/zenodo.3555357
title: Large-scale purification of Q23 HTT from Sf9 2019/09/30

description: <strong>Project: </strong>Biophysical investigation of purified HTT protein samples <strong>Experiment: </strong>Large-scale purification of Q23 HTT from Sf9 <strong>Date completed:­ </strong>2019/09/30 <strong>Rationale: </strong>HTT samples are to be purified from different systems for subsequent biophysical and structural studies.
description: Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
DOI: 10.5281/zenodo.3522005
title: Assembly and variant calling results of strain mixtures of HCMV

description: The tgz files contain the assembly contigs of 10 different assemblers and variant calling results of 6 callers on the strain mixture dataset of the HCMV virus.
DOI: 10.5281/zenodo.3522006
title: Assembly and variants calling results of strain mixtures of HCMV

description: The tgz file contains the assembly contigs of 8 different assemblers and SNP calling results of 5 callers on the strain mixture dataset of the HCMV virus.
DOI: 10.5281/zenodo.3555360
title: Purification of HTT Q23 and Q54 from EXPI293F for mass spectrometry analysis 2019/09/30

description: <strong>Project: </strong>Biophysical investigation of purified HTT protein samples <strong>Experiment: </strong>Purification of Q23 and Q54 HTT from EXPI293F <strong>Date completed:­ </strong>2019/09/30 <strong>Rationale: </strong>Purify HTT Q23 and Q54 for mass spectrometry analysis
description: Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.